KODIAK SCIENCES INC (KOD)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for KOD
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| KOD | Director; Board Member | 66 | ["Leadership roles in commercial, strategy and finance at Bristol-Myers Squibb","Chief Financial Officer of Bristol-Myers Squibb from January 2010 to November 2019","Independent director of GSK","Independent director of Biovector, Inc.","Member of the board of directors of Colgate-Palmolive Company from January 2017 to March 2020","Bachelor's degree from Drexel University","M.B.A. from Temple University"] | ["Audit","Compensation","Nominating and Governance","Nominating and Corporate Governance"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| CL | Chief Financial Officer and Executive Vice President, Global Business Operations; Director | 59 | ["Chief Financial Officer and Executive Vice President, Global Business Operations, Bristol-Myers Squibb Company", "Business Operations: Extensive knowledge of business finance and financial statements through service as Chief Financial Officer of, and holding various senior financial positions at, Bristol-Myers Squibb.", "Industry: In-depth knowledge of the pharmaceutical industry, a complementary industry, through experience at Bristol-Myers Squibb.", "Regulatory: Experience working in a highly regulated industry, the pharmaceutical industry, through service at Bristol-Myers Squibb.", "International: Experience managing Bristol-Myers Squibb\u2019s international operations and living and working in foreign countries.", "audit committee financial expert"] | ["AUD", "FIN", "GOV", "P&O", "Audit", "Finance", "Audit Committee", "Finance Committee"] | 2019 |